MASSDEVICE ON CALL — California biotech startup Organovo has its sights set high, promising to demonstrate the promise of 3D bio-printing technology by unveiling a human organ made of printed living cells by the end the year.
Organovo plans to begin organ-printing with the human liver, constructed by laying down layer after layer of human tissue to form a single organ. To do so, the company needs to develop a sort of vascular system to keep the organ fed with nutrients and oxygen, lest it wither on the printer.
Even if Organovo manages to keep the liver alive, it won’t likely be ready for human transplantation any time soon, suitable instead for testing drugs and conducting scientific research, Business Insider reported.
Abbott says goodbye to Canada plant
After years of phased layoffs, Abbott (NYSE:ABT) last month shuttered its Brockville, Ontario, manufacturing facility a year after it was originally slated to close.
Read more
St. Jude Medical opens another Minnesota facility
Minnesota medtech titan St. Jude Medical (NYSE:STJ) leased a new warehouse in its home state, taking over an industrial building boasting some 185,000-square feet.
Read more
Boston Scientific sales jobs are a hot commodity
Boston Scientific (NYSE:BSX) landed in the top 3 of 2014’s 3 Best Places to Work in Medical Sales, according to MedReps.com.
Read more
Digital fork watches what you eat
The new "smart" HAPIfork uses an embedded accelerometer and vibration feedback to warn users to slow down their eating, although it may have a few kinks to work out before becoming a mass commodity.
Read more
